Sourris Karly C, Lyons Jasmine G, de Courten Maximilian P J, Dougherty Sonia L, Henstridge Darren C, Cooper Mark E, Hage Michelle, Dart Anthony, Kingwell Bronwyn A, Forbes Josephine M, de Courten Barbora
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Diabetes. 2009 Jun;58(6):1259-65. doi: 10.2337/db08-1725. Epub 2009 Mar 3.
Chronic low-grade activation of the immune system (CLAIS) predicts type 2 diabetes via a decrease in insulin sensitivity. Our study investigated potential relationships between nuclear factor-kappaB (NF-kappaB) and c-Jun NH(2)-terminal kinase (JNK) pathways-two pathways proposed as the link between CLAIS and insulin resistance.
Adiposity (dual-energy X-ray absorptiometry), waist-to-hip ratio (WHR), and insulin sensitivity (M, hyperinsulinemic-euglycemic clamp) were measured in 22 healthy nondiabetic volunteers (aged 29 +/- 11 years, body fat 28 +/- 11%). NF-kappaB activity (DNA-binding assay) and JNK1/2 activity (phosphorylated JNK) were assessed in biopsies of the vastus lateralis muscle and subcutaneous adipose tissue and in peripheral blood mononuclear cell (PBMC) lysates.
NF-kappaB activities in PBMCs and muscle were positively associated with WHR after adjustment for age, sex, and percent body fat (both P < 0.05). NF-kappaB activity in PBMCs was inversely associated with M after adjustment for age, sex, percent body fat, and WHR (P = 0.02) and explained 16% of the variance of M. There were no significant relationships between NF-kappaB activity and M in muscle or adipose tissue (both NS). Adipose-derived JNK1/2 activity was not associated with obesity (all P> 0.1), although it was inversely related to M (r = -0.54, P < 0.05) and explained 29% of its variance. When both NF-kappaB and JNK1/2 were examined statistically, only JNK1/2 activity in adipose tissue was a significant determinant of insulin resistance (P = 0.02).
JNK1/2 activity in adipose tissue but not NF-kappaB activity in PBMCs is an independent determinant of insulin resistance in healthy individuals.
免疫系统的慢性低度激活(CLAIS)通过降低胰岛素敏感性来预测2型糖尿病。我们的研究调查了核因子-κB(NF-κB)和c-Jun氨基末端激酶(JNK)信号通路之间的潜在关系——这两条信号通路被认为是CLAIS与胰岛素抵抗之间的联系。
对22名健康非糖尿病志愿者(年龄29±11岁,体脂28±11%)进行肥胖(双能X线吸收法)、腰臀比(WHR)和胰岛素敏感性(M值,高胰岛素-正糖钳夹技术)的测量。在股外侧肌活检组织、皮下脂肪组织以及外周血单核细胞(PBMC)裂解物中评估NF-κB活性(DNA结合试验)和JNK1/2活性(磷酸化JNK)。
在校正年龄、性别和体脂百分比后,PBMC和肌肉中的NF-κB活性与WHR呈正相关(P均<0.05)。在校正年龄、性别、体脂百分比和WHR后,PBMC中的NF-κB活性与M值呈负相关(P = 0.02),并解释了M值16%的变异。肌肉或脂肪组织中的NF-κB活性与M值之间无显著关系(均无统计学意义)。脂肪组织来源的JNK1/2活性与肥胖无关(所有P>0.1),尽管它与M值呈负相关(r = -0.54,P < 0.05),并解释了其29%的变异。当对NF-κB和JNK1/2进行统计学分析时,只有脂肪组织中的JNK1/2活性是胰岛素抵抗的显著决定因素(P = 0.02)。
脂肪组织中的JNK1/2活性而非PBMC中的NF-κB活性是健康个体胰岛素抵抗的独立决定因素。